Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study.

Cohen JA, Comi G, Arnold DL, Bar-Or A, Selmaj KW, Steinman L, Havrdová EK, Cree BA, Montalbán X, Hartung HP, Huang V, Frohna P, Skolnick BE, Kappos L; RADIANCE Trial Investigators.

Mult Scler. 2019 Aug;25(9):1255-1262. doi: 10.1177/1352458518789884. Epub 2018 Jul 25.

2.

The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.

Gomperts E, Belcher JD, Otterbein LE, Coates TD, Wood J, Skolnick BE, Levy H, Vercellotti GM.

Am J Hematol. 2017 Jun;92(6):569-582. doi: 10.1002/ajh.24750. Epub 2017 Apr 29. Review.

3.

Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trial.

Allez M, Skolnick BE, Wisniewska-Jarosinska M, Petryka R, Overgaard RV.

Gut. 2017 Nov;66(11):1918-1925. doi: 10.1136/gutjnl-2016-311824. Epub 2016 Aug 3.

PMID:
27489241
4.

Neuroprotection Trials in Traumatic Brain Injury.

Chakraborty S, Skolnick B, Narayan RK.

Curr Neurol Neurosci Rep. 2016 Apr;16(4):29. doi: 10.1007/s11910-016-0625-x. Review.

PMID:
26883431
5.

First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis.

Gottlieb AB, Krueger JG, Sandberg Lundblad M, Göthberg M, Skolnick BE.

PLoS One. 2015 Aug 7;10(8):e0134703. doi: 10.1371/journal.pone.0134703. eCollection 2015.

6.

Progesterone in traumatic brain injury.

Skolnick BE, Maas AI, Narayan RK; SYNAPSE Steering Committee.

N Engl J Med. 2015 Apr 30;372(18):1767. doi: 10.1056/NEJMc1503138. No abstract available.

PMID:
25932489
7.

A clinical trial of progesterone for severe traumatic brain injury.

Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N; SYNAPSE Trial Investigators.

N Engl J Med. 2014 Dec 25;371(26):2467-76. doi: 10.1056/NEJMoa1411090. Epub 2014 Dec 10.

8.

Quantitative CT densitometry for predicting intracerebral hemorrhage growth.

Barras CD, Tress BM, Christensen S, Collins M, Desmond PM, Skolnick BE, Mayer SA, Davis SM; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators.

AJNR Am J Neuroradiol. 2013 Jun-Jul;34(6):1139-44. doi: 10.3174/ajnr.A3375. Epub 2013 Jan 10.

9.

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study.

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Anesth Analg. 2011 Oct;113(4):703-10. doi: 10.1213/ANE.0b013e318228c690. Epub 2011 Sep 2.

PMID:
21890888
10.

Stroke: working toward a prioritized world agenda.

Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC Jr, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J.

Int J Stroke. 2010 Aug;5(4):238-56. doi: 10.1111/j.1747-4949.2010.00442.x.

11.

Stroke: working toward a prioritized world agenda.

Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC Jr, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J; Stroke Synergium.

Cerebrovasc Dis. 2010;30(2):127-47. doi: 10.1159/000315099. Epub 2010 May 24.

12.

Stroke: working toward a prioritized world agenda.

Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC Jr, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J.

Stroke. 2010 Jun;41(6):1084-99. doi: 10.1161/STROKEAHA.110.586156. Review.

13.

Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects.

Skolnick BE, Mathews DR, Khutoryansky NM, Pusateri AE, Carr ME.

Blood. 2010 Aug 5;116(5):693-701. doi: 10.1182/blood-2009-11-253492. Epub 2010 Apr 12. Erratum in: Blood. 2010 Dec 2;116(23):5079.

PMID:
20385794
14.

Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.

Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, Broderick JP.

Stroke. 2010 Jan;41(1):48-53. doi: 10.1161/STROKEAHA.109.561712. Epub 2009 Dec 3.

PMID:
19959538
15.

Density and shape as CT predictors of intracerebral hemorrhage growth.

Barras CD, Tress BM, Christensen S, MacGregor L, Collins M, Desmond PM, Skolnick BE, Mayer SA, Broderick JP, Diringer MN, Steiner T, Davis SM; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators.

Stroke. 2009 Apr;40(4):1325-31. doi: 10.1161/STROKEAHA.108.536888. Epub 2009 Mar 12.

PMID:
19286590
16.

Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?

Mayer SA, Davis SM, Skolnick BE, Brun NC, Begtrup K, Broderick JP, Diringer MN, Steiner T; FAST trial investigators.

Stroke. 2009 Mar;40(3):833-40. doi: 10.1161/STROKEAHA.108.524470. Epub 2009 Jan 15.

PMID:
19150875
17.

Timing is everything in intracerebral hemorrhage.

Steiner T, Broderick J, Brun NC, Davis SM, Diringer MN, Mayer S, Skolnick BE.

Stroke. 2008 Jul;39(7):e117-8; author reply e119-20. doi: 10.1161/STROKEAHA.108.517979. Epub 2008 May 22. No abstract available.

PMID:
18497323
18.

Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial.

Narayan RK, Maas AI, Marshall LF, Servadei F, Skolnick BE, Tillinger MN; rFVIIa Traumatic ICH Study Group.

Neurosurgery. 2008 Apr;62(4):776-86; discussion 786-8. doi: 10.1227/01.neu.0000316898.78371.74.

PMID:
18496183
19.

Progression of traumatic intracerebral hemorrhage: a prospective observational study.

Narayan RK, Maas AI, Servadei F, Skolnick BE, Tillinger MN, Marshall LF; Traumatic Intracerebral Hemorrhage Study Group.

J Neurotrauma. 2008 Jun;25(6):629-39. doi: 10.1089/neu.2007.0385.

PMID:
18491950
20.

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; FAST Trial Investigators.

N Engl J Med. 2008 May 15;358(20):2127-37. doi: 10.1056/NEJMoa0707534.

21.

Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.

Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, Broderick JP.

Stroke. 2008 Mar;39(3):850-6. doi: 10.1161/STROKEAHA.107.493601. Epub 2008 Jan 31.

PMID:
18239180
22.

Cerebral hemodynamics, autoregulation, and blood pressure management.

Feldmann E, Skolnick BE.

J Stroke Cerebrovasc Dis. 1999 May-Jun;8(3):176-82. No abstract available.

PMID:
17895161
23.

Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage.

Diringer MN, Ferran JM, Broderick J, Davis S, Mayer SA, Steiner T, Brun NC, Skolnick BE, Christensen MC.

Cerebrovasc Dis. 2007;24(2-3):219-25. Epub 2007 Jun 28.

PMID:
17630481
24.

Determinants of intracerebral hemorrhage growth: an exploratory analysis.

Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T, Skolnick BE, Davis SM; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators.

Stroke. 2007 Mar;38(3):1072-5. Epub 2007 Feb 8.

PMID:
17290026
25.

Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.

Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J, Skolnick BE, Davis SM.

Neurosurgery. 2006 Oct;59(4):767-73; discussion 773-4.

PMID:
17038942
26.

Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.

Mayer SA, Brun NC, Broderick J, Davis SM, Diringer MN, Skolnick BE, Steiner T; United States NovoSeven ICH Trial Investigators.

Neurocrit Care. 2006;4(3):206-14.

PMID:
16757825
27.

Radiologic estimation of hematoma volume in intracerebral hemorrhage trial by CT scan.

Zimmerman RD, Maldjian JA, Brun NC, Horvath B, Skolnick BE.

AJNR Am J Neuroradiol. 2006 Mar;27(3):666-70.

28.

Recombinant activated factor VII for acute intracerebral hemorrhage.

Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators.

N Engl J Med. 2005 Feb 24;352(8):777-85.

29.

Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.

Mayer SA, Brun NC, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T; Europe/AustralAsia NovoSeven ICH Trial Investigators.

Stroke. 2005 Jan;36(1):74-9. Epub 2004 Nov 29.

PMID:
15569871
30.

Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety.

Simuni T, Jaggi JL, Mulholland H, Hurtig HI, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH.

J Neurosurg. 2002 Apr;96(4):666-72.

PMID:
11990805
31.

Revision of deep brain stimulator for tremor. Technical note.

Schwalb JM, Riina HA, Skolnick B, Jaggi JL, Simuni T, Baltuch GH.

J Neurosurg. 2001 Jun;94(6):1010-2.

PMID:
11409503
32.

Long-term deep brain stimulation in a patient with essential tremor: clinical response and postmortem correlation with stimulator termination sites in ventral thalamus. Case report.

Boockvar JA, Telfeian A, Baltuch GH, Skolnick B, Simuni T, Stern M, Schmidt ML, Trojanowski JQ.

J Neurosurg. 2000 Jul;93(1):140-4.

PMID:
10883919
34.

Targeting for thalamic deep brain stimulator implantation without computer guidance: assessment of targeting accuracy.

Alterman RL, Reiter GT, Shils J, Skolnick B, Arle JE, Lesutis M, Simuni T, Colcher A, Stern M, Hurtig H.

Stereotact Funct Neurosurg. 1999;72(2-4):150-3.

PMID:
10853070
35.

Guidelines for acute stroke treatment centers.

Skolnick BE.

Phys Med Rehabil Clin N Am. 1999 Nov;10(4):801-13, viii. Review.

PMID:
10573708
36.

Ethical and institutional review board issues.

Skolnick BE.

Adv Neurol. 1998;76:253-62. Review.

PMID:
9408484
37.

Relationship of 133Xe cerebral blood flow to middle cerebral arterial flow velocity in men at rest.

Clark JM, Skolnick BE, Gelfand R, Farber RE, Stierheim M, Stevens WC, Beck G Jr, Lambertsen CJ.

J Cereb Blood Flow Metab. 1996 Nov;16(6):1255-62.

PMID:
8898699
38.

Neurological deficits during duplex carotid imaging.

Siddiqui MA, Skolnick BE, Kochar GS.

J Am Geriatr Soc. 1996 Mar;44(3):338-9. No abstract available.

PMID:
8600216
39.

Bispectral analysis of visual interactions in humans.

Shils JL, Litt M, Skolnick BE, Stecker MM.

Electroencephalogr Clin Neurophysiol. 1996 Feb;98(2):113-25.

PMID:
8598171
40.

Cerebral blood flow during spike-wave discharges.

Sperling MR, Skolnick BE.

Epilepsia. 1995 Feb;36(2):156-63.

PMID:
7821273
41.
42.

Lateralized increases in cerebral blood flow during performance of verbal and spatial tasks: relationship with performance level.

Gur RC, Ragland JD, Resnick SM, Skolnick BE, Jaggi J, Muenz L, Gur RE.

Brain Cogn. 1994 Mar;24(2):244-58.

PMID:
8185896
43.

Effects of hypnosis on regional cerebral blood flow during ischemic pain with and without suggested hypnotic analgesia.

Crawford HJ, Gur RC, Skolnick B, Gur RE, Benson DM.

Int J Psychophysiol. 1993 Nov;15(3):181-95.

PMID:
8166843
44.

Reliability of regional cerebral blood flow activation to cognitive tasks in elderly normal subjects.

Skolnick BE, Gur RC, Stern MB, Hurtig HI.

J Cereb Blood Flow Metab. 1993 May;13(3):448-53.

PMID:
8478403
45.

Role of the Institutional Review Board in clinical trials.

Skolnick BE.

Epilepsy Res Suppl. 1993;10:193-200. Review. No abstract available.

PMID:
8251097
46.

Decreases in frontal and parietal lobe regional cerebral blood flow related to habituation.

Warach S, Gur RC, Gur RE, Skolnick BE, Obrist WD, Reivich M.

J Cereb Blood Flow Metab. 1992 Jul;12(4):546-53.

PMID:
1618933
47.

Facial emotion discrimination: I. Task construction and behavioral findings in normal subjects.

Erwin RJ, Gur RC, Gur RE, Skolnick B, Mawhinney-Hee M, Smailis J.

Psychiatry Res. 1992 Jun;42(3):231-40.

PMID:
1496055
48.

Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes.

Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI.

Neurology. 1989 Nov;39(11):1524-6.

PMID:
2812334
49.

Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers.

Amsterdam JD, Maislin G, Skolnick B, Berwish N, Winokur A.

Biol Psychiatry. 1989 Jul;26(3):265-78.

PMID:
2742943
50.

Effects of task difficulty on regional cerebral blood flow: relationships with anxiety and performance.

Gur RC, Gur RE, Skolnick BE, Resnick SM, Silver FL, Chawluk J, Muenz L, Obrist WD, Reivich M.

Psychophysiology. 1988 Jul;25(4):392-9. No abstract available.

PMID:
3174905

Supplemental Content

Loading ...
Support Center